Comparison of the analgesic effect of ibuprofen with mesalamine after discectomy surgery in patients with lumbar disc herniation: A double-blind randomized controlled trial

Neurology India

Volumn 57, Issue 3, 2009, Pages 305-309

  Toroudi, Hamidreza ^a   Razavi, Mohammad ^b,c   Razavi, Hamid ^a   Tabatabayi, Reza ^a   Tabar, Yaser ^a   Yahyavi, Seyyed ^a   Montazer, Mehdi ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN University of Medical Science ^*  (Iran)

Author keywords

Discectomy; Ibuprofen; Mesalamine; Pain; Visual analogue scale

Indexed keywords

IBUPROFEN; MESALAZINE; METHADONE;

ADULT; AMBLYOPIA; ANALGESIA; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; EDEMA; FEMALE; HEADACHE; HUMAN; INTERVERTEBRAL DISKECTOMY; LUMBAR DISK HERNIA; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PAIN ASSESSMENT; POSTOPERATIVE PAIN; PREOPERATIVE EVALUATION; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SODIUM RETENTION; STATISTICAL SIGNIFICANCE; STOMACH ULCER; STUDENT T TEST; TERATOGENICITY; THROMBOCYTOPENIA; VERTIGO; VISUAL ANALOG SCALE; VISUAL IMPAIRMENT; WATER RETENTION;

ADULT; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CONFIDENCE INTERVALS; DISKECTOMY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IBUPROFEN; INTERVERTEBRAL DISK DISPLACEMENT; LUMBAR VERTEBRAE; MALE; MESALAMINE; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; TIME FACTORS;

EID: 67651152821     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.53292     Document Type: Article

References (22)

1. Skovron ML, Szpalski M, Nordin M, Melot C, Cukier D. Sociocultural factors and back pain: A population-based study in Belgian adult. Spine 1994;19:129-137 (Pubitemid 24047298)
2. Cassidy JD. Carrol LJ, Cote P. The Saskatchewan Health and back pain survey: The prevalence of low back pain and related disability in Saskatchewan adults. Spine 1998;23:1860-1866 (Pubitemid 28432482)
3. Carragee E, Cohen S. Reliability of LBP history in asymptomatic subjects? The prevalence and incidence of reported back pain correlates with surveillance frequency. In proceedings of 19th annual meeting of the North American Spine Ssociety, Chicago: October 26-30, 2004;216.
4. Khanapure SP, Garvey DS, Janero DR, Letts LG. Eicosanoids in inflammation: Biosynthesis, pharmacology, and therapeutic frontiers. Curr Top Med Chem 2007;7:311-340
5. Stenson WF, Lobos E. Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils. J Clin Investig 1982;69:494-497 (Pubitemid 12177629)
6. Nielsen OH, Verspaget HW, Elmgreen J. Inhibition of intestinal macrophage chemotaxis to leukotriene B4 by sulphasalazine, olsalazine, and 5-aminosalicylic acid. Aliment Pharmacol Ther 1988l;2:203-211
7. Rachmilewitz D, Karmeli F, Schwartz LW, Simon PL. Effect of Aminopbenols (5-ASA and 4-ASA) on colonic interleukin-l generation. Gut 1992;33:929-932
8. Tokui K, Asai Y, Arakawa T, Matsumoto T, Nabeshima T. Comparative absorption of 5-aminosalicylic acid (5-ASA) after administration of a 5-ASA enema and salazosulf2pyridine (SASP) after an SASP suppository in Japanese volunteers. Biol Pharm Bull 2002;25:264-267 (Pubitemid 39592119)
9. Sandborn WJ, Hanauer SB, Buch A. Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral Mesalamine (Asacol) and balsalazide: A randomized, single-dose, crossover study in healthy volunteers. Aliment Pharmacol Ther 2004;19:1089-1098 (Pubitemid 38703521)
10. Toliison CD, Satterthwaite JR, Tollison JW. Practical pain management. 3rd ed. Lippincott Wil1iams and Wilkins; 2002.p.124.
11. Sugisaki K, Honma F, Iwadate H, Shio K, Shiova Y, Fukava E, et al. Ulcerative colitis occurring in the course of rheumatoid arthritis: A case successfully treated with Mesalamine enema. Intern Med 2004;43:1046-1050 (Pubitemid 39619121)
12. Bird HA. Sulphasajazine, sulphapyridine or 5-aminosalicylic acid which is the active moiety in rheumatoid arthritis? Br J Rheumatol 1995;34:16-19
13. van der Horst-Bruinsma IE, Clegg DO, Dijkmans A. Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs. Clin Exp Rheumatol 2002;20:S67-70.
14. Toussirot E, Wendling D. Current guidelines for the drug treatment of ankylosing spondylitis. Drugs 1998;56:225-240 (Pubitemid 28391519)
15. Dougados M, Dijkmans B, Khan M, Maksymowych W, van der Linden S, Brandt J. Conventional treatments for ankylosing spondylitis. Ann Rheum Dis 2002;61:iii40-50.
16. Ahnfelt-Ronne I, Nielsen OH. The anti-inflammatory moiety of Sulfasalazine, 5-minosalicylic acid, is a radical scavenger. Agents Actions 1987;21:191-194 (Pubitemid 17118325)
17. Aruoma OI, Wasil M, Halliwell B, Hoey BM, Butler J. The scavenging of oxidants by sulphasalazine and its metabolites: A possible contribution to their anti-in1lammatory effects? Biochem Pharmacol 1987;36:3739-3742
18. Gaginella TS, Walsh RE. Sulfasalazine: Multiplicity of action. Dig Dis Sci 1992;37:801-812
19. Greenfield SM, Punchard NA, Tear JP, Thomposon RP. The mode of action of the aminosalicylates in inflammatory bowel disease. Aliment Pharmacol Ther 1993;7:369-383 (Pubitemid 23267013)
20. Hardman JG, Limbird LE, Goodman Gilman A. Goodman and Gilman's The Pharmacological Basis of Therapeutics. Chapter 39. 10th ed. 2001. p. 1050.
21. Hardman JG, Limbird LE, Goodman Gilman A. Goodman and Gilman's The Pharmacological Basis of Therapeutics. Chapter 27. 10th ed. 2001. p. 712.
22. Charlesbrunicardi F, Andersen DK, Billiar TR, Dunn D, Hunter JG, Pollok RE. Schwartz's principles of surgery. Chapter 41. 8th ed. 2005. p. 1641.